PR Newswire Consumer Products
pressLeft
Shareholders who lost money in shares of acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) should contact Wolf Haldenstein Immediatelytranslating…
Lead Plaintiff Deadline October 13, 2026 NEW YORK and SAN DIEGO, Aug. 31, 2026 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a nationally recognized securities litigation law firm, announces that a securities class action lawsuit has been filed…
Keywords#Wolf Haldenstein#AARD#Aardvark#Aardvark Therapeutics#Haldenstein Immediately